Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from XTEK Limited ( (AU:HCL) ).
HighCom Limited reported that all resolutions put to shareholders at its 23 March general meeting were passed by poll, including multiple items related to the ratification and issuance of placement shares. The strong approval levels, with more than 90 per cent of votes cast in favour across all resolutions, clear the way for tranche two placement share issues to directors and support the company’s ongoing capital management and growth plans.
The meeting outcomes reinforce the company’s ability to execute its funding strategy while maintaining shareholder backing, which is important as HighCom continues to expand its armour manufacturing and defence technology integration businesses. The support for issuing additional shares to directors also signals investor confidence in the leadership team steering the group’s operations in global protective equipment and Australian defence technology markets.
The most recent analyst rating on (AU:HCL) stock is a Hold with a A$0.32 price target. To see the full list of analyst forecasts on XTEK Limited stock, see the AU:HCL Stock Forecast page.
More about XTEK Limited
HighCom Limited, listed on the ASX as HCL, operates through two main businesses, HighCom Armor and HighCom Technology. HighCom Armor designs, manufactures, and supplies advanced ballistic body armour, helmets, and composite armour panels and structures to global military, law enforcement, and first responder customers. HighCom Technology serves Australian defence and security agencies as a technology integrator, providing uncrewed aerial systems, sensor payloads, and a range of engineering, maintenance, and logistics support services.
Average Trading Volume: 260,581
Technical Sentiment Signal: Sell
Current Market Cap: A$25.8M
See more data about HCL stock on TipRanks’ Stock Analysis page.

